Cleared Traditional

K132407 - VITAL SIGNS PATCH SYSTEM (IN SHORT VSP)

K132407 is an FDA 510(k) clearance for VITAL SIGNS PATCH SYSTEM (IN SHORT VSP), manufactured by Lifewatch Technologies , Ltd.. The device is a Class 2 Cardiovascular device with product code DSI cleared through the Traditional 510(k) pathway after a 504-day FDA review.

K132407 · Lifewatch Technologies , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
504d
Days
Class 2
Risk

K132407 is an FDA 510(k) clearance for the VITAL SIGNS PATCH SYSTEM (IN SHORT VSP). Classified as Detector And Alarm, Arrhythmia (product code DSI), Class II - Special Controls.

Submitted by Lifewatch Technologies , Ltd. (Rehovot, IL). The FDA issued a Cleared decision on December 19, 2014 after a review of 504 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Lifewatch Technologies , Ltd. devices

FDA 510(k) Submission Details - K132407

510(k) Number K132407 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 2013
Decision Date December 19, 2014
Days to Decision 504 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
379d slower than avg
Panel avg: 125d · This submission: 504d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DSI Device Classification - Class 2, Special Controls

Product Code DSI Detector And Alarm, Arrhythmia
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSI Detector And Alarm, Arrhythmia

All 262
Devices cleared under the same product code (DSI) and FDA review panel - the closest regulatory comparables to K132407.
Medtronic Patient Asistant
K150117 · Medtronic, Inc. · May 2015
IntelliVue Patient Monitor
K150310 · Philips Medizin Systeme Boeblingen GmbH · May 2015
MENNTOR X7
K141441 · Mennen Medical , Ltd. · Jan 2015
ACUITY CENTRAL MONITORING STATION OR ACUITY CENTRAL MONITORING SYSTEM, MOBILE ACUITY LT, MOBILE ACUITY, MOBILE LT
K120774 · Welch Allyn, Inc. · Apr 2012
INTELLIVUE MX40 PATIENT MONITOR
K113125 · Philips Medical Systems · Nov 2011
REVEAL XT INSERTABLE CARDIAC MONITOR, MODEL 9529 AND REVEAL DX INSERTABLE CARDIAC MONITOR, MODEL 9528
K103764 · Medtronic, Inc. · May 2011